These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 19549584)

  • 1. Identification of bisindolylmaleimides and indolocarbazoles as inhibitors of HCV replication by tube-capture-RT-PCR.
    Murakami Y; Noguchi K; Yamagoe S; Suzuki T; Wakita T; Fukazawa H
    Antiviral Res; 2009 Aug; 83(2):112-7. PubMed ID: 19549584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel epoxide inhibitors of hepatitis C virus replication using a high-throughput screen.
    Peng LF; Kim SS; Matchacheep S; Lei X; Su S; Lin W; Runguphan W; Choe WH; Sakamoto N; Ikeda M; Kato N; Beeler AB; Porco JA; Schreiber SL; Chung RT
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3756-9. PubMed ID: 17682098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A serine palmitoyltransferase inhibitor blocks hepatitis C virus replication in human hepatocytes.
    Katsume A; Tokunaga Y; Hirata Y; Munakata T; Saito M; Hayashi H; Okamoto K; Ohmori Y; Kusanagi I; Fujiwara S; Tsukuda T; Aoki Y; Klumpp K; Tsukiyama-Kohara K; El-Gohary A; Sudoh M; Kohara M
    Gastroenterology; 2013 Oct; 145(4):865-73. PubMed ID: 23791700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for hepatitis C virus antiviral activity with a cell-based secreted alkaline phosphatase reporter replicon system.
    Bourne N; Pyles RB; Yi M; Veselenak RL; Davis MM; Lemon SM
    Antiviral Res; 2005 Aug; 67(2):76-82. PubMed ID: 15927278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus complete life cycle screen for identification of small molecules with pro- or antiviral activity.
    Gentzsch J; Hinkelmann B; Kaderali L; Irschik H; Jansen R; Sasse F; Frank R; Pietschmann T
    Antiviral Res; 2011 Feb; 89(2):136-48. PubMed ID: 21167208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput screening of HCV RNA replication inhibitors by means of a reporter replicon system.
    Hao W; Duggal R
    Methods Mol Biol; 2009; 510():243-50. PubMed ID: 19009266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System.
    Nakajima S; Watashi K; Ohashi H; Kamisuki S; Izaguirre-Carbonell J; Kwon AT; Suzuki H; Kataoka M; Tsukuda S; Okada M; Moi ML; Takeuchi T; Arita M; Suzuki R; Aizaki H; Kato T; Suzuki T; Hasegawa H; Takasaki T; Sugawara F; Wakita T
    J Virol; 2016 Oct; 90(20):9058-74. PubMed ID: 27489280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New aspects of an anti-tumour drug: sorafenib efficiently inhibits HCV replication.
    Himmelsbach K; Sauter D; Baumert TF; Ludwig L; Blum HE; Hildt E
    Gut; 2009 Dec; 58(12):1644-53. PubMed ID: 19710032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a cell-based assay for high-throughput screening of inhibitors against HCV genotypes 1a and 1b in a single well.
    Mondal R; Koev G; Pilot-Matias T; He Y; Ng T; Kati W; Molla A
    Antiviral Res; 2009 Apr; 82(1):82-8. PubMed ID: 19174175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
    Yu M; Corsa AC; Xu S; Peng B; Gong R; Lee YJ; Chan K; Mo H; Delaney W; Cheng G
    Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a robust luciferase reporter 1b/2a hepatitis C virus (HCV) for characterization of early stage HCV life cycle inhibitors.
    Chan K; Robinson M; Yang H; Cornew S; Delaney Iv WE
    Antiviral Res; 2013 Apr; 98(1):85-92. PubMed ID: 23376631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation systems for anti-HCV drugs.
    Moriishi K; Matsuura Y
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1213-21. PubMed ID: 17720275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
    Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K
    Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoid derivative Tp80 exhibits anti-hepatitis C virus activity through restoration of GI-GPx expression.
    Nguyen BN; Okuno Y; Ajiro M; Iida K; Denawa M; Yamamoto M; Sakamoto N; Kagechika H; Hagiwara M
    J Med Virol; 2017 Jul; 89(7):1224-1234. PubMed ID: 27922182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel small-molecule inhibitor of hepatitis C virus replication acts by suppressing signal transducer and activator of transcription 3.
    Niu Y; Si Y; Li Y; Chi X; Li X; Liu X; Li D; Cheng M; Fan J; Si S; Yang W
    J Antimicrob Chemother; 2015 Jul; 70(7):2013-23. PubMed ID: 25858355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
    Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
    J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A zebrafish model for subgenomic hepatitis C virus replication.
    Ding CB; Zhao Y; Zhang JP; Peng ZG; Song DQ; Jiang JD
    Int J Mol Med; 2015 Mar; 35(3):791-7. PubMed ID: 25572289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A reliable internally controlled RT-nested PCR method for the detection of hepatitis C virus RNA.
    Nozaki A; Naganuma A; Nakamura T; Tanaka K; Sekihara H; Kato N
    Acta Med Okayama; 2000 Dec; 54(6):253-7. PubMed ID: 11132918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shape-based virtual screening, synthesis and evaluation of novel pyrrolone derivatives as antiviral agents against HCV.
    Bassetto M; Leyssen P; Neyts J; Yerukhimovich MM; Frick DN; Brancale A
    Bioorg Med Chem Lett; 2017 Feb; 27(4):936-940. PubMed ID: 28089348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of hepatitis C virus RNA replicons by peptide aptamers.
    Trahtenherts A; Gal-Tanamy M; Zemel R; Bachmatov L; Loewenstein S; Tur-Kaspa R; Benhar I
    Antiviral Res; 2008 Mar; 77(3):195-205. PubMed ID: 18243349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.